14 July 2017 – EXCiPACT Workshop, Shanghai, China

Workshop programme

8:00 – 9:00 Registration
9:00 – 9:30 How EXCiPACT GMP/GDP Certification Adds Value to Pharmaceutical industry VP Board EXCiPACT Asbl.;

Global Head Audit GMP, Group Compliance & Audit, Novartis International AG

–    Ms. Sarbari Roy, Ph.D.

9:30 – 10:10 Key Points of GMP/GDP Local Inspection on Excipients Suppliers and Viewpoints to Third Party Certification Market Supervision and Administration Bureau Minhang District of Shanghai

–    Ms. Leifei Wang, Deputy Director General

10:10 – 10:30 Tea Break
10:30 – 11:30 IPEC Risk Assessment Guide / Regulatory Compliant Requirements Vice Chair, IPEC China

Regulatory Affair Manager, FMC China

–   Mr. Martin Tao

11:30 – 12:00 Update on quality and regulatory initiatives in US and Europe VP Board EXCiPACT Asbl.;

Global Head Audit GMP, Group Compliance & Audit, Novartis International AG

–    Ms. Sarbari Roy, Ph.D.

12:00 – 12:15 EXCiPACT Latest Development and Updates Consultant of EXCiPACT (China);

Oufan Consulting Co., Ltd.

–    Mr. Nevin Cheng, Ph.D.

12:15 – 12:30 Q&A
12:30 – 13:30 Lunch
13:30- 14:05 Case Study - User Perspective to EXCiPACT Certification Scheme Multinational Pharmaceutical Company (TBD)

–    TBD

14:05- 14:40 Case Study - Experience and Benefits gained from EXCiPACT Certification Deputy General Manager, Nanjing Duoyuan Biochemistry Co., Ltd.

–    Mr. Chaojun Wang

14:40 – 15:00 Tea Break
15:00 – 15:45 Certifying Body’s Perspective – SGS’s Audit Findings of EXCiPACT Certification Globally in Different Categories Senior Technical Executive, Life Science Auditing, Global Products & Services Development, SGS

–    Mr. Felix Gao

15:45- 16:30 How to Prepare for EXCiPACT Certification Consultant of EXCiPACT (China);

Oufan Consulting Co., Ltd.

–    Mr. Nevin Cheng Ph.D.

16:30- 17:00 Q & A
Closing Remarks

To download the programme, please click here

Interested parties should contact Mr Nevin Cheng at nevin.cheng {at} hotmail.com

 

Comments are closed.